A high-efficiency system for the generation and study of human induced pluripotent stem cells.
Direct reprogramming of human fibroblasts to a pluripotent state has been achieved through ectopic expression of the transcription factors OCT4, SOX2, and either cMYC and KLF4 or NANOG and LIN28. Little is known, however, about the mechanisms by which reprogramming occurs, which is in part limited by the low efficiency of conversion. To this end, we sought to create a doxycycline-inducible lentiviral system to convert primary human fibroblasts and keratinocytes into human induced pluripotent stem cells (hiPSCs). hiPSCs generated with this system were molecularly and functionally similar to human embryonic stem cells (hESCs), demonstrated by gene expression profiles, DNA methylation status, and differentiation potential. While expression of the viral transgenes was required for several weeks in fibroblasts, we found that 10 days was sufficient for the reprogramming of keratinocytes. Using our inducible system, we developed a strategy to induce hiPSC formation at high frequency. Upon addition of doxycycline to hiPSC-derived differentiated cells, we obtained "secondary" hiPSCs at a frequency at least 100-fold greater than the initial conversion. The ability to reprogram cells at high efficiency provides a unique platform to dissect the underlying molecular and biochemical processes that accompany nuclear reprogramming.
Maherali
Nimet
N
Department of Stem Cell and Regenerative Biology, Harvard Stem Cell Institute, Massachusetts General Hospital Center for Regenerative Medicine, Massachusetts General Hospital Cancer Center, Boston, MA 02114, USA.
Ahfeldt
Tim
T
Rigamonti
Alessandra
A
Utikal
Jochen
J
Cowan
Chad
C
Hochedlinger
Konrad
K
D054337:Cell Dedifferentiation; D065150:Cellular Reprogramming; D003584:Cytological Techniques / Q000379:methods*; D005347:Fibroblasts / Q000378:metabolism; D005821:Genetic Techniques; D005822:Genetic Vectors / Q000378:metabolism; D006801:Humans; D000090062:Kruppel-Like Factor 4; D016086:Lentivirus / Q000235:genetics; D039904:Pluripotent Stem Cells / Q000378:metabolism*
Nature. 2007 Jul 19;448(7151):313-7
17554338
Nat Biotechnol. 2008 Aug;26(8):916-24
18594521
Curr Biol. 2008 Jun 24;18(12):890-4
18501604
Cell Stem Cell. 2008 Mar 6;2(3):230-40
18371448
Bioinformatics. 2006 May 1;22(9):1111-21
16522673
Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):2883-8
18287077
Dev Cell. 2008 Jun;14(6):818-29
18539112
Science. 2008 Aug 1;321(5889):699-702
18276851
Nat Biotechnol. 2008 Jul;26(7):795-7
18568017
Science. 2007 Dec 21;318(5858):1917-20
18029452
Nature. 2008 Jan 10;451(7175):141-6
18157115
Cell. 2006 Aug 25;126(4):663-76
16904174
Cell Stem Cell. 2007 Jun 7;1(1):55-70
18371336
Nature. 2007 Jul 19;448(7151):318-24
17554336
Cell. 2008 Apr 18;133(2):250-64
18423197
Nat Genet. 2000 Apr;24(4):372-6
10742100
Cell. 2007 Nov 30;131(5):861-72
18035408
Nature. 2008 Jul 3;454(7200):49-55
18509334
Stem Cells. 2008 Apr;26(4):903-11
18238855